Teva Nixes Suit Against Apotex Over Parkinson's Drug
Teva Pharmaceuticals agreed to drop its patent infringement claims against Apotex Corp. in Florida federal court on Thursday, ending the short-lived battle over a generic version of Parkinson's disease drug Azilect. ...To view the full article, register now.
Already a subscriber? Click here to view full article